Moneycontrol PRO
HomeNewsBusinessMarketsDabur India shares slip 4% after muted Q4; Should you buy, sell or hold?

Dabur India shares slip 4% after muted Q4; Should you buy, sell or hold?

Brokerages largely retained ratings on Dabur India while flagging demand headwinds and mixed segment performance

May 08, 2025 / 10:52 IST
dabur

Muted Q4 and cautious outlook keep Dabur under close watch

Shares of Dabur India slipped 4 percent to Rs 461 apiece on May 8 after the company posted a subdued performance for the March quarter. Most brokerages maintained their ratings, with the company guiding for high-single digit sales growth in FY26.

Macquarie retained a "neutral" rating on Dabur with a target price of Rs 480 per share, noting that the Q4 operational performance was broadly in line. “The company expects a gradual recovery, supported by the impact of a 3.5 to 4 percent price hike implemented in the fourth quarter,” it said.

Nuvama Institutional Equities, however, cut its target price to Rs 615 per share from Rs 635, citing sluggish urban demand.

Catch all the market action on our LIVE blog

“We are trimming our FY26 and FY27 estimates by 4.8 percent and 3 percent, respectively,” the brokerage stated. It highlighted that the home and personal care (HPC) segment underperformed due to a high base, healthcare took a hit from a mild winter, and beverages were impacted by an unseasonal quarter.

Citi maintained its “Sell” rating but raised the target price to Rs 470 from Rs 450. It flagged continued pressures on both growth and margins, stating that Dabur ended FY25 with a broadly weak performance. Citi noted it would be watching to see whether the company’s refreshed strategy could lead to a sustainable pickup.

For Q4, Dabur reported an 8.4 percent year-on-year decline in consolidated net profit to Rs 320.13 crore. Revenue from operations rose a marginal 0.5 percent year-on-year to Rs 2,830 crore.

EBITDA for the quarter came in at Rs 426.8 crore, down 8.6 percent from the previous year. Margins stood at 15.1 percent compared to 16.6 percent a year ago.

Within segments, the healthcare business—about 30 percent of overall revenue—was down 4.7 percent year-on-year, impacted by a milder winter. Home and personal care, the company’s largest segment, declined 3.3 percent.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News
first published: May 8, 2025 08:16 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347